Replies to post #1380 on PDS Biotechnology Corp (PDSB)

[conix]

PDS Biotechnology (NASDAQ:PDSB) had its price target raised by analysts at HC Wainwright from $8.00 to $20.00 on Wednesday. They now have a "buy" rating on the stock. They noted that the move was a valuation call.This represents a 56.5% upside from the current price of $12.78.